NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Editor's Pick

WATCH: Parody drug ad spotlights RFK’s crackdown on misleading pharmaceutical marketing

by September 18, 2025
written by September 18, 2025

Shortly after announcing a strategy to go after deceptive direct-to-consumer advertising by the pharmaceutical industry, Robert F. Kennedy Jr. and the Department of Health and Human Services released a parody video of a drug advertisement – a pointed way of emphasizing the fact that the United States is largely unique in allowing drug ads.

‘Tired of endless drug ads promising quick fixes but leaving you sicker than you were before? That can change today. Ask your doctor about MAHA,’ the parody commercial begins, referring to Kennedy’s ‘Make America Healthy Again’ initiative. 

‘MAHA may cause healthier living, fewer chronic diseases, and lower drug costs,’ the video’s narrator continues. ‘Some Americans reported more time spent with family instead of at the pharmacy. Other side effects may include healthier children, a stronger nation, more transparency in healthcare, honest advertising, and accountability from Big Pharma.’

The drug advertisement parody comes after Kennedy and HHS laid out their plans to target direct-to-consumer drug advertising – something that isn’t widely allowed outside the United States – in a new children’s health strategy released earlier this month. 

The strategy said it will ramp up enforcement of current prescription drug advertising laws, with a priority on ‘egregious violations demonstrating harm from current practices.’ The strategy noted these violations could include the dissemination of ‘risk information and quality of life through misleading and deceptive advertising on social media and digital platforms.’

The strategy to go after direct-to-consumer drug ads will also include inter-agency cooperation to explore the development of potential new industry guidelines that limit direct-to-consumer advertising for certain ‘unhealthy foods’ to children. These efforts include ‘evaluating the use of misleading claims and imagery,’ the MAHA children’s strategy stated. 

Kennedy said alongside the release of HHS’s parody advertisement that the Trump administration plans to begin holding the pharmaceutical industry accountable for not sharing full safety information in their drug ads on television, radio and beyond.

 

‘No more hiding vital information in small print, or pushing it off to a website, or a 1-800 number,’ Kennedy said in a video released in conjunction with the parody advertisement. He also noted that regulators have been letting pharmaceutical manufacturers avoid providing complete warnings in their marketing materials.

Kennedy said in the accompanying video that, in the past, regulators let companies mention a vague ‘major statement’ of risk that required consumers to go elsewhere for important details about the drug. The secretary said this ‘loophole’ opened the door to a ‘tsunami’ of misleading advertisements.

‘Drug ads drove up prescription drug costs and distorted doctor-patient conversations. Patients saw glossy ads and often asked for new medications,’ Kennedy continued. ‘Big Pharma’s marketing hooked the country on prescription drugs. We’re taking action to end that practice.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
DC watchdog sues for docs on ‘modern-day Tuskegee Experiments’ giving transgender Rx to youth
next post
SCOOP: Ilhan Omar hit with House Ethics complaint over response to Charlie Kirk’s assassination

You may also like

SCOOP: Ilhan Omar hit with House Ethics complaint...

September 19, 2025

Senate confirms dozens of Trump nominees in first...

September 18, 2025

Hunter Biden was involved in pardon talks toward...

September 18, 2025

DC watchdog sues for docs on ‘modern-day Tuskegee...

September 18, 2025

Trump renews attacks on Biden autopen pardons, claims...

September 18, 2025

Schumer accuses Trump of exploiting Charlie Kirk’s death...

September 18, 2025

Turning Point USA elects Erika Kirk as new...

September 18, 2025

Trump: Putin has ‘really let me down’ on...

September 18, 2025

Thune pans Democrats’ shutdown stance as ‘borderline pathological,’...

September 18, 2025

Trump administration asks Supreme Court to allow firing...

September 18, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!




    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular Posts

    • 1

      Oil and natural gas: Oil is back on the positive side

    • 2

      The dollar index continues to pull back to a new low

    • 3

      Gold and Silver: Gold remains stable in the $2420 zone

    • 4

      IonQ Stock Review: Should You Consider Investing Now?

    • 5

      Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

    Recent Posts

    • SCOOP: Ilhan Omar hit with House Ethics complaint over response to Charlie Kirk’s assassination

      September 19, 2025
    • Hunter Biden was involved in pardon talks toward end of father’s term, source says

      September 18, 2025
    • WATCH: Parody drug ad spotlights RFK’s crackdown on misleading pharmaceutical marketing

      September 18, 2025
    • Senate confirms dozens of Trump nominees in first test of new nuclear rules

      September 18, 2025
    • DC watchdog sues for docs on ‘modern-day Tuskegee Experiments’ giving transgender Rx to youth

      September 18, 2025

    Categories

    • Economy (20)
    • Editor's Pick (349)
    • Investing (20)
    • Stock (39)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 NewTradingView.com All Rights Reserved.


    Back To Top
    NewTradingView.com – Investing and Stock News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick